Briggs Morrison

Insider Reports History

Entity
Individual
Location
C/O Syndax Pharmaceuticals, Inc., 400 Totten Pond Road, Suite 110, Waltham, MA
Signature
/s/ Richard Morris, as Attorney-in-Fact for Briggs Morrison
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Briggs Morrison:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ARVINAS, INC. Director Common Stock 30K $1.41M $47.05 May 29, 2024 Direct
Syndax Pharmaceuticals Inc Director Common Stock 34.8K $636K $18.27 Feb 7, 2024 Direct
ARVINAS, INC. Director Stock Option (right to buy) 9.07K $145K $16.00 May 29, 2024 Direct
Repare Therapeutics Inc. Director Stock Option (right to buy) 27.2K Jun 17, 2024 Direct
Carisma Therapeutics Inc. Director Stock Option (Right to Buy) 19.4K Jun 26, 2024 Direct
Werewolf Therapeutics, Inc. Director Stock Option (right to buy) 17.5K May 24, 2024 Direct
Syndax Pharmaceuticals Inc Director Stock Options (Right to buy) 0 $25.84 Aug 9, 2023 Direct

Insider Reports Filed by Briggs Morrison

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CARM Carisma Therapeutics Inc. Jun 26, 2024 1 $0 4 Jun 27, 2024 Director
RPTX Repare Therapeutics Inc. Jun 17, 2024 1 $0 4 Jun 20, 2024 Director
ARVN ARVINAS, INC. May 29, 2024 2 $0 4 May 31, 2024 Director
HOWL Werewolf Therapeutics, Inc. May 24, 2024 1 $0 4 May 24, 2024 Director
SNDX Syndax Pharmaceuticals Inc Feb 7, 2024 1 $0 4 Feb 9, 2024 Director
SNDX Syndax Pharmaceuticals Inc Aug 9, 2023 3 -$502K 4 Aug 10, 2023 Director
SNDX Syndax Pharmaceuticals Inc Jul 10, 2023 3 -$615K 4 Jul 11, 2023 Director
HOWL Werewolf Therapeutics, Inc. Jun 21, 2023 1 $0 4 Jun 23, 2023 Director
ARVN ARVINAS, INC. Jun 15, 2023 2 $0 4 Jun 20, 2023 Director
SNDX Syndax Pharmaceuticals Inc Jun 9, 2023 6 -$715K 4 Jun 9, 2023 Director
RPTX Repare Therapeutics Inc. Jun 8, 2023 1 $0 4 Jun 12, 2023 Director
CARM Carisma Therapeutics Inc. Jun 6, 2023 1 $0 4 Jun 8, 2023 Director
SNDX Syndax Pharmaceuticals Inc May 9, 2023 3 -$794K 4 May 10, 2023 Director
SNDX Syndax Pharmaceuticals Inc Apr 10, 2023 3 -$695K 4 Apr 12, 2023 Director
SNDX Syndax Pharmaceuticals Inc Mar 13, 2023 3 -$853K 4 Mar 14, 2023 President, Head of R&D, Director
CARM Carisma Therapeutics Inc. Mar 7, 2023 3 $0 4 Mar 9, 2023 Director
CARM Carisma Therapeutics Inc. Mar 7, 2023 0 $0 3 Mar 9, 2023 Director
SNDX Syndax Pharmaceuticals Inc Feb 6, 2023 3 -$1.08M 4 Feb 8, 2023 President, Head of R&D, Director
SNDX Syndax Pharmaceuticals Inc Feb 2, 2023 1 $914K 4 Feb 3, 2023 President, Head of R&D, Director
SNDX Syndax Pharmaceuticals Inc Sep 19, 2022 6 -$2.12M 4 Sep 21, 2022 President, Head of R&D, Director
SNDX Syndax Pharmaceuticals Inc Sep 14, 2022 12 -$4.4M 4 Sep 16, 2022 President, Head of R&D, Director
SNDX Syndax Pharmaceuticals Inc Jul 1, 2022 3 -$735K 4 Jul 5, 2022 President, Head of R&D, Director
ARVN ARVINAS, INC. Jun 16, 2022 1 $0 4 Jun 21, 2022 Director
HOWL Werewolf Therapeutics, Inc. Jun 1, 2022 1 $0 4 Jun 3, 2022 Director
RPTX Repare Therapeutics Inc. May 13, 2022 1 $0 4 May 16, 2022 Director
ARVN ARVINAS, INC. Apr 14, 2022 5 -$1.13M 4 Apr 18, 2022 Director
SNDX Syndax Pharmaceuticals Inc Apr 1, 2022 4 $530K 4/A Apr 13, 2022 President, Head of R&D, Director
SNDX Syndax Pharmaceuticals Inc Feb 2, 2022 1 $2.53M 4 Feb 3, 2022 President, Head of R&D, Director
ARVN ARVINAS, INC. Jan 14, 2022 6 -$1.12M 4 Jan 19, 2022 Director
SNDX Syndax Pharmaceuticals Inc Dec 17, 2021 3 -$320K 4 Dec 20, 2021 Chief Executive Officer, Director
SNDX Syndax Pharmaceuticals Inc Sep 17, 2021 6 -$905K 4 Sep 21, 2021 Chief Executive Officer, Director
ARVN ARVINAS, INC. Jun 8, 2021 1 $0 4 Jun 10, 2021 Director
RPTX Repare Therapeutics Inc. May 13, 2021 1 $0 4 May 14, 2021 Director